Despite strong revenue, Lifecome Biochemistry's growth rates...

Despite strong revenue, Lifecome Biochemistry's growth rates lag behind the industry's predicted 842% growth. Investors may face disappointment if P/S falls in line with recent growth rates. The company's poor three-year revenue trends aren't resulting in a lower P/S as expected. Without significant medium-term performance improvement, preventing P/S ratio decline will be challenging.